Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of a 68Ga-Labeled B7-H3 Nanobody for ImmunoPET Imaging in Patients With Osteosarcoma

NCT07774533 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT07774533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07774533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of a 68Ga-Labeled B7-H3 Nanobody for ImmunoPET Imaging in Patients With Osteosarcoma
Lead sponsor
Peking University First Hospital
Phase
Phase 1
Overall status
Recruiting
Start date
April 1, 2026
Completion date
September 30, 2026
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteosarcoma, osteosarcoma, recurrent, refractory